A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VANGA BHASMA AND JATHIPALA CHOORNA IN SHUKRAGATA VATA W.S.R. PREMATURE EJACULATION

Sexual dysfunctions are increasingly becoming a major health problem in todays world due to changes in sedentary life style food habits socio-cultural changes and influence of media. The prevalence of sexual dysfunction is high affecting 25-40of men. Premature ejaculation is one such example resulting in lot of dissatisfaction and intolerance creating differences in the married life1 .Masters and Johnson conceptualized this disorder in terms of the couple and considered man a premature ejaculator if he cannot control ejaculation for a sufficient length of time during intravaginal containment to satisfy his partner in at least half of their episodes of coitus 2. Acharaya Charaka in Vata Vyadhi Chikitsa explained Kshiprammunchyath as one of the lakshana of Shukragata Vata. Chakrapani further commented during Vyavaya Kala there will be Kshipra Munchana which means the person will have early ejaculation during sexual intercourse3 . The treatment Harshana and Balya to Shukra has been indicated4 .In RasaTarangini5 Vanga bhasma is been explained to behaving similar properties amp Sharangadhara samhita mentioned among Vajikarana dravyas Jathiphala as Shukra Stambhaka6 .The present study is a comparative clinical study with pre-test and post-test design where in 40 male patients diagnosed with Shukragata vata w.s.r to Premature ejaculation were randomly assigned into two groups comprising of 20 patients each. It is a Single blind open randomized trial parallel designed two groups were made and the patients in Group-Awere administered Vanga Bhasma and Jathiphala choorna and the patients in Group-B were administered Vanga Bhasma. The study was conducted for a period of 30 days.The t-value in Group-Ais greater than Group-B in the parameters of Ability to delay ejaculation Erection Rigidity Desire and Orgasm. The t-value is greater in Group-B than in Group-A in parameter performance anxiety. The overall effect of the treatment is 2972.55 patients had moderately improved615 patients were unchanged 512.5 patients markedly improved and none of the patients condition got worsened.